Migrants from sub-Saharan Africa in the Swiss HIV cohort study: A single center study of epidemiologic migration-specific and clinical features

AIDS Patient Care and STDs

Volumn 18, Issue 11, 2004, Pages 665-675

  Staehelin, Cornelia ^a   Egloff, Niklaus ^a   Rickenbach, Martin ^b   Kopp, Christine ^c   Furrer, Hansjakob ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Swiss HIV Cohort Study Data Center   (Switzerland)

^c FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICA; AGE DISTRIBUTION; ANEMIA; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; DRUG INDICATION; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH PROMOTION; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL INFORMATION; MIGRATION; PATIENT REFERRAL; POPULATION RESEARCH; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEX RATIO; SOUTHEAST ASIA; SWITZERLAND; VULNERABLE POPULATION;

EID: 9644304537     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2004.18.665     Document Type: Article

References (21)

1. Bundesamt für Gesundheit. AIDS und HIV in der Schweiz. Epidemiologische Situation Ende 2002. Bern: Bundesamt für Gesundheit, Epidemiologie und Infektionskrankheiten, 2003.
2. Staehelin C, Rickenbach M, Low N, et al. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: Access to antiretroviral therapy, disease progression and survival. AIDS 2003;17:2237-2244.
3. Sudre P, Rickenbach M, Taffé P, et al. Clinical epidemiology and research on HIV infection in Switzerland: The Swiss HIV Cohort Study 1988-2000. Schweiz Med Wochenschr 2000;130:1493-1500.
4. Centers for Disease Control. 1993 Classification system for HIV infection and expanded surveillance case definition for acquired immunodeficiency syndrome (AIDS) among adolescents and adults. MMWR 1992; 41(RR-17):1-19.
5. Gebhardt M, Rickenbach M, Egger M, and the Swiss HIV Cohort Study. Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland. AIDS 1998;12:1195-1201.
6. Piot P, Bartos M, Ghys PD, Walker N, Schwartlander B. The global impact of HIV/AIDS. Nature 2001;410: 968-973.
7. Manfredi R, Calza L, Chiodo F. HIV disease among immigrants coming to Italy from outside of the European Union: A case-control study of epidemiological and clinical features. Epidemiol Infect 2001;127: 527-533.
8. Colucci A, Covre P, D'Agostini A, et al. Immigration and health: the Italian situation. Italian National Focal Point (NFP) of the AIDS & Mobility Project. Ann 1st Super Sanita 1998;34:473-487.
9. Gras MJ, Weide JF, Langendam MW, Coutinho RA, van den HA. HIV prevalence, sexual risk behaviour and sexual mixing patterns among migrants in Amsterdam, The Netherlands. AIDS 1999;13:1953-1962.
10. Sinka K, Mortimer J, Evans B, Morgan D. Impact of the HIV epidemic in sub-Saharan Africa on the pattern of HIV in the UK. AIDS 2003;17:1683-1690.
11. Morgan D, Mahe C, Mayanja B, Whitworth JA. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. BMJ 2002;324:193-196.
12. Del Amo J, Petruckevitch A, Phillips A, et al. Disease progression and survival in HIV-1-infected Africans in London. AIDS 1998;12:1203-1209.
13. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. BMJ. 1997;315:1194-1199.
14. Ledergerber B, Egger M, Erard V, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study. JAMA 1999;282:2220-2226.
15. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 2002;360:119-129.
16. Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Lancet 1999;353:863-868.
17. Salamon R, Marimoutou C, Ekra D, et al. Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Cote d'Ivoire, 1997-2000. J Acquir Immune Defic Syndr 2002;29:149-157.
18. Lundgren JD, Mocroft A, Gatell JM, et al. A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: Results from the EuroSIDA study. J Infect Dis 2002;185:178-187.
19. Bassetti S, Battegay M, Furrer H, et al. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol 1999;21:114-119.
20. Del Amo J, Broring G, Fenton K. HIV health experiences among migrant Africans in Europe: How are we doing? AIDS 2003;17:2261-2263.
21. Zuppinger B, Kopp C, Wicker H-R. Interventionsplan HIV/AIDS- Prävention bei Sub-Sahara MigrantInnen. Bern: Bundesamt für Gesundheit, 2000.